Treprostinil
Products Treprostinil is commercially available as an infusion solution (Remodulin, generic). It has been approved in many countries since 2004. Structure and properties Treprostinil (C23H34O5, Mr = 390.5 g/mol) is a synthetic prostacyclin. Effects Treprostinil (ATC B01AC21) has vasodilator and antiplatelet properties. Indications Primary pulmonary hypertension Pulmonary arterial hypertension